Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

CATX
Perspective Therapeutics, Inc.
stock NYSEAMERICAN

Market Open
Aug 3, 2026 9:45:58 AM EDT
2.89USD-0.687%(-0.02)59,500
2.88Bid   2.90Ask   0.02Spread
Pre-market
Aug 3, 2026 8:19:30 AM EDT
2.91USD0.000%(0.00)942
After-hours
Jul 31, 2026 4:10:30 PM EDT
2.91USD+0.345%(+0.01)0
OverviewOption ChainMax PainOptionsPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrends
open chart   
open chart   
Market Cap
329.59M
Headquarters
Richland, Washington, USA
Industry
Medical Devices
Next Earnings
Aug 12, 2026 (9d)
Last Split
Jun 17, 20241for10reverse
CATX Stats
Avg. Vol. 10 Day
849,641
Avg. Vol. 30 Day
2,070,468
Employees
66
Market Cap
329,593,509
Shares Out.
114,046,197
On/Off Exchange
63%/37%
6 Month Beta
1.48
1 Year Beta
0.98
2 Year Beta
1.49
3 Year Beta
1.48
52 Week Low
1.96
52 Week High
6.16
SMA50
3.24
SMA200
3.54
1 Week
+2.48%
1 Month
-20.39%
3 Month
-27.39%
6 Month
-44.42%
1 Year
-25.71%
2 Year
-76.49%
5 Year
-18.20%
Profile
the introduction of cesium-131 represents the culmination of decades of work and millions of dollars of investment. top medical centers, hospitals and clinics across the united states are now offering this breakthrough treatment for cancer patients. the word brachytherapy derives from the greek prefix brachy, meaning "short" or "close," because the titanium capsules containing the radioisotope are implanted directly into the cancerous prostate gland. treatment of cancer using low dose radiation or "seed" brachytherapy was pioneered in the 1960's as an effective alternative to radical prostatectomy. pioneers in brachytherapy research initially theorized about the use of cesium-131 in a titanium capsule, however scientific and economic limitations at the time prevented its development and iodine-125 emerged as an alternative. beginning in 1967, iodine-125 became the first radioisotope manufactured in a titanium capsule, or seed. while its use continues to this day, many patients and doct

CATX Stock Summary

Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) stock price today is $2.89, and today's volume is 59,500. CATX is down -0.687% today. The 30 day average volume is 2,070,468. CATX market cap is 329.59M with 114,046,197 shares outstanding.



Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC